Amanda Ceas, Anastasia Jimenez, Yun Liu, Mariana De Niz, Lisandra Vila Ellis
{"title":"Endothelial Continuum and Capillary Specialization in Pulmonary Vascular Development.","authors":"Amanda Ceas, Anastasia Jimenez, Yun Liu, Mariana De Niz, Lisandra Vila Ellis","doi":"10.1161/ATVBAHA.126.322483","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary vascular development requires coordinated growth, remodeling, and specialization of the endothelial network to support airway branching and alveolar formation. Recent advances in single-cell and spatial transcriptomics have revealed that endothelial cells are organized along a transcriptional arteriovenous spectrum while simultaneously adopting region-specific identities within the capillary bed. In particular, the emergence of distinct alveolar capillary populations, including capillary endothelial cell type 1 and capillary endothelial cell type 2 cells, highlights previously unappreciated heterogeneity. Parallel studies further demonstrate that macrovascular and microvascular identities are influenced by positional context, vessel caliber, and flow-associated transcriptional programs. Together, these insights redefine how endothelial specialization is established during lung development. Here, we review current understanding of pulmonary vascular morphogenesis, endothelial fate specification, and capillary diversification and discuss how emerging imaging platforms may help connect molecular identity with spatial organization and dynamic cellular behavior.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":"e322483"},"PeriodicalIF":8.8000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13336269/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.126.322483","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pulmonary vascular development requires coordinated growth, remodeling, and specialization of the endothelial network to support airway branching and alveolar formation. Recent advances in single-cell and spatial transcriptomics have revealed that endothelial cells are organized along a transcriptional arteriovenous spectrum while simultaneously adopting region-specific identities within the capillary bed. In particular, the emergence of distinct alveolar capillary populations, including capillary endothelial cell type 1 and capillary endothelial cell type 2 cells, highlights previously unappreciated heterogeneity. Parallel studies further demonstrate that macrovascular and microvascular identities are influenced by positional context, vessel caliber, and flow-associated transcriptional programs. Together, these insights redefine how endothelial specialization is established during lung development. Here, we review current understanding of pulmonary vascular morphogenesis, endothelial fate specification, and capillary diversification and discuss how emerging imaging platforms may help connect molecular identity with spatial organization and dynamic cellular behavior.
期刊介绍:
The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA).
The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.